Nitin MD - Zimmer Biomet Technology Science
ZIM Stock | EUR 98.22 0.16 0.16% |
Insider
Nitin MD is Technology Science of Zimmer Biomet Holdings
Phone | 574 267 6131 |
Web | https://www.zimmerbiomet.com |
Zimmer Biomet Management Efficiency
The company has return on total asset (ROA) of 0.0371 % which means that it generated a profit of $0.0371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0236 %, meaning that it generated $0.0236 on every $100 dollars invested by stockholders. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities.Zimmer Biomet Holdings has accumulated 5.32 B in total debt with debt to equity ratio (D/E) of 74.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Zimmer Biomet Holdings has a current ratio of 1.17, suggesting that it may not have the ability to pay its financial obligations in time and when they become due. Debt can assist Zimmer Biomet until it has trouble settling it off, either with new capital or with free cash flow. So, Zimmer Biomet's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Zimmer Biomet Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Zimmer to invest in growth at high rates of return. When we think about Zimmer Biomet's use of debt, we should always consider it together with cash and equity.
Similar Executives
Found 13 records | INSIDER Age | ||
Akira Kanazawa | Canon Marketing Japan | N/A | |
Tsuyoshi Osato | Canon Marketing Japan | N/A | |
Minoru Mizoguchi | Canon Marketing Japan | N/A | |
Hatsumi Hirukawa | Canon Marketing Japan | N/A | |
KlausGerd Kleversaat | Tradegate AG Wertpapierhandelsb | N/A | |
Toshio Matsumoto | Canon Marketing Japan | N/A | |
Holger Timm | Tradegate AG Wertpapierhandelsb | N/A | |
Koichi Mikami | Canon Marketing Japan | N/A | |
Masachika Adachi | Canon Marketing Japan | 63 | |
Thorsten Commichau | Tradegate AG Wertpapierhandelsb | N/A | |
Jorg Hartmann | Tradegate AG Wertpapierhandelsb | N/A | |
Karsten Haesen | Tradegate AG Wertpapierhandelsb | N/A | |
Kerstin Timm | Tradegate AG Wertpapierhandelsb | N/A |
Management Performance
Return On Equity | 0.0236 | |||
Return On Asset | 0.0371 |
Zimmer Biomet Holdings Leadership Team
Elected by the shareholders, the Zimmer Biomet's board of directors comprises two types of representatives: Zimmer Biomet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zimmer. The board's role is to monitor Zimmer Biomet's management team and ensure that shareholders' interests are well served. Zimmer Biomet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zimmer Biomet's outside directors are responsible for providing unbiased perspectives on the board's policies.
Chad Phipps, Gen VP | ||
Ivan Tornos, Chief Officer | ||
Sang Yi, Group Pacific | ||
Paul Stellato, Controller VP | ||
Keri Mattox, Chief Relations | ||
Wilfred Zuilen, Middle Europe | ||
Suketu Upadhyay, Ex CFO | ||
Zeeshan Tariq, VP Officer | ||
Bryan Hanson, Pres Chairman | ||
Nitin MD, Technology Science |
Zimmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zimmer Biomet a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0236 | |||
Return On Asset | 0.0371 | |||
Profit Margin | 0.03 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | 29.79 B | |||
Shares Outstanding | 210.06 M | |||
Shares Owned By Institutions | 90.95 % | |||
Price To Earning | 10.60 X | |||
Price To Book | 2.15 X | |||
Price To Sales | 3.27 X |
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.